Learn / TRVI
NASDAQ: TRVI
Trevi Therapeutics (TRVI) stock, explained like you're 5
Trevi Therapeutics trades on the Nasdaq under the ticker TRVI. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
- Ticker
- TRVI
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.9 billion dollars
Is Trevi Therapeutics a small, medium or large cap company?
No. Trevi Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.9 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Trevi Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves TRVI stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Trevi Therapeutics, Inc. (TRVI) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Trevi Therapeutics (TRVI) Institutional Ownership 2026 $TRVI (MarketBeat)
- Patients reported early, sustained improvement in a chronic cough trial (Stock Titan)
- Trevi Therapeutics Inc Share Price TRVI, RNS News, Articles, Quotes, & Charts (NASDAQ: TRVI) (Proactive financial news)
- Trevi Therapeutics (TRVI) Following Its Pullback Still Carries An Undervalued Narrative (Simply Wall Street)
Follow TRVI in your daily brief
Each trading day at 5 PM ET we post what happened to Trevi Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow TRVI
Questions about Trevi Therapeutics stock
What does Trevi Therapeutics do?
Trevi Therapeutics trades on the Nasdaq under the ticker TRVI. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
What is the ticker symbol for Trevi Therapeutics?
Trevi Therapeutics trades under the ticker TRVI on the Nasdaq.
What is Trevi Therapeutics's market cap?
Trevi Therapeutics is a small cap stock with a market cap of about 1.9 billion dollars.
How does Trevi Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves TRVI stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow TRVI stock every day?
Add TRVI to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.